GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synbio Tech Inc (ROCO:1295) » Definitions » Asset Turnover

Synbio Tech (ROCO:1295) Asset Turnover : 0.23 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Synbio Tech Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Synbio Tech's Revenue for the three months ended in Jun. 2024 was NT$469.7 Mil. Synbio Tech's Total Assets for the quarter that ended in Jun. 2024 was NT$2,003.6 Mil. Therefore, Synbio Tech's Asset Turnover for the quarter that ended in Jun. 2024 was 0.23.

Asset Turnover is linked to ROE % through Du Pont Formula. Synbio Tech's annualized ROE % for the quarter that ended in Jun. 2024 was 37.74%. It is also linked to ROA % through Du Pont Formula. Synbio Tech's annualized ROA % for the quarter that ended in Jun. 2024 was 18.28%.


Synbio Tech Asset Turnover Historical Data

The historical data trend for Synbio Tech's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synbio Tech Asset Turnover Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Asset Turnover
0.53 0.59 0.46 0.46

Synbio Tech Quarterly Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Asset Turnover Get a 7-Day Free Trial 0.25 0.22 0.22 0.24 0.23

Competitive Comparison of Synbio Tech's Asset Turnover

For the Biotechnology subindustry, Synbio Tech's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synbio Tech's Asset Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synbio Tech's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Synbio Tech's Asset Turnover falls into.



Synbio Tech Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Synbio Tech's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=823.304/( (1676.754+1886.24)/ 2 )
=823.304/1781.497
=0.46

Synbio Tech's Asset Turnover for the quarter that ended in Jun. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Jun. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Jun. 2024 ))/ count )
=469.66/( (1886.24+2121.048)/ 2 )
=469.66/2003.644
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Synbio Tech  (ROCO:1295) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Synbio Tech's annulized ROE % for the quarter that ended in Jun. 2024 is

ROE %**(Q: Jun. 2024 )
=Net Income/Total Stockholders Equity
=366.296/970.471
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(366.296 / 1878.64)*(1878.64 / 2003.644)*(2003.644/ 970.471)
=Net Margin %*Asset Turnover*Equity Multiplier
=19.5 %*0.9376*2.0646
=ROA %*Equity Multiplier
=18.28 %*2.0646
=37.74 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Synbio Tech's annulized ROA % for the quarter that ended in Jun. 2024 is

ROA %(Q: Jun. 2024 )
=Net Income/Total Assets
=366.296/2003.644
=(Net Income / Revenue)*(Revenue / Total Assets)
=(366.296 / 1878.64)*(1878.64 / 2003.644)
=Net Margin %*Asset Turnover
=19.5 %*0.9376
=18.28 %

Note: The Net Income data used here is four times the quarterly (Jun. 2024) net income data. The Revenue data used here is four times the quarterly (Jun. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Synbio Tech Asset Turnover Related Terms

Thank you for viewing the detailed overview of Synbio Tech's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Synbio Tech Business Description

Traded in Other Exchanges
N/A
Address
No.66, Beiling 6th Road, Luzhu District, Kaohsiung, TWN
Synbio Tech Inc is a company specializing in the research, manufacturing, and application development of lactic acid bacteria. The company provides lactic acid bacteria screening, functional research and verification, and the introduction of advanced processes to produce safe and stable high-quality bacterial powder, OEM, ODM customized finished products, share application development technology, provide excellent service quality, and gain recognition from customers.

Synbio Tech Headlines

No Headlines